PHAROS CAPITAL GROUP, LLC

Thesis

Pharos Capital Group is a physician-founded private equity firm established in 1998, with a distinct focus on investing in growing U.S. healthcare and business services companies. The firm's core mission is to improve patient outcomes, increase access to care, and lower the total cost of healthcare, with a particular emphasis on serving underserved communities and populations. Pharos Capital Group operates with a contrarian investment thesis, deliberately avoiding legacy, volume-driven healthcare models in favor of value-based, outcomes-oriented businesses. They primarily target companies within the healthcare and business services sectors, with specific focus areas including provider services, managed care services, behavioral health, wellness, disease and/or population management, diagnostic technology and services, medical device companies with FDA-approved technology, healthcare data analytics and outcomes measurement, and telemedicine. They specifically seek companies that reduce the total cost of care, improve access, and leverage data and analytics, such as those involved in early chronic disease detection and care coordination. The firm emphasizes investing in undercapitalized businesses in underserved regions across the nation, including rural and urban communities. Pharos Capital Group engages in control equity and growth equity investments, as well as mezzanine financing. They typically invest between $25 million and $50 million per platform company, targeting businesses with enterprise values in the lower to middle market range. Pharos Capital Group prefers companies with strong market positions, sustainable competitive advantages, and a track record of profitability, often seeking businesses with revenues of at least $10 million and EBITDA of at least $2 million, and a growth rate of 20% or more. As of June 30, 202

Related lists

• Series C+ Healthcare investors
• Series C+ investors based in Dallas, TX